This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Adam, R. M. Articles by Freeman, M. R. Search for Related Content PubMed PubMed Citation Articles by Adam, R. M. Articles by Freeman, M. R.

Cholesterol Sensitivity of Endogenous and Myristoylated Akt

¹ The Urological Diseases Research Center and ² Department of Orthopedic Surgery, Children's Hospital Boston; Departments of ³ Surgery and ⁴ Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts

Requests for reprints: Michael R. Freeman, The Urological Diseases Research Center, Enders Research Laboratories, Room 1161, Children's Hospital Boston, 300 Longwood Avenue, Boston, MA 02115. Phone: 617-919-2644; Fax: 617-730-0238; E-mail: michael.freeman{at}childrens.harvard.edu and Rosalyn M. Adam, The Urological Diseases Research Center, Enders Research Laboratories, Room 1077, Children's Hospital Boston, 300 Longwood Avenue, Boston, MA 02115. Phone: 617-919-2019; Fax: 617-730-0248; E-mail: rosalyn.adam{at}childrens.harvard.edu.

The serine-threonine kinase, Akt, has been linked to cholesterol-sensitive signaling mechanisms, suggesting a possible means whereby cholesterol might affect tumor cell growth and survival. However, it has not been shown whether Akt itself, as distinct from upstream components of the pathway (e.g., membrane phosphoinositides), can be directly responsible for cholesterol-mediated effects. Consistent with this possibility, we identified an Akt1 subpopulation in cholesterol-rich lipid raft fractions prepared from LNCaP human prostate cancer cells. Phosphorylation of this Akt subspecies was ablated with methyl-ß-cyclodextrin, a cholesterol-binding compound, under conditions where nonlipid raft-resident Akt was unaffected. A myristoylated Akt1 (MyrAkt1) fusion protein expressed in LNCaP cells was found to be highly enriched in lipid rafts, indicating that oncogenic Akt is overrepresented in cholesterol-rich membranes compared with wild-type Akt. Notably, lipid raft-resident MyrAkt1 exhibited a markedly distinct substrate preference compared with MyrAkt1 immunoprecipitated from cytosol and nonraft membrane fractions, suggesting a redirection of signal transduction when the protein is present in cholesterol-rich membranes. Expression of MyrAkt1 in LNCaP cells overcame their characteristic dependence on constitutive signaling through the phosphoinositide 3'-kinase pathway. This protective effect was substantially diminished with cyclodextrin treatment. Phosphorylation of Akt substrates in lipid raft fractions, but not in cytosol/nonraft membrane fractions, was ablated with cyclodextrin. In addition, in control (LacZ transfected) cells, lipid raft fractions were relatively enriched in phosphorylated Akt substrates. Collectively, these data show that a subpopulation of Akt is cholesterol sensitive and that the oncogenic effects conferred by myristoylation arise, in part, from the tendency of the membrane-targeted form of the protein to reside in cholesterol-rich membrane microdomains. [Cancer Res 2007;67(13):6238–46]

This article has been cited by other articles:

				L. Calleros, I. Sanchez-Hernandez, P. Baquero, M. J. Toro, and A. Chiloeches Oncogenic Ras, but not V600EB-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells Carcinogenesis, October 1, 2009; 30(10): 1670 - 1677. [Abstract] [Full Text] [PDF]

				D. Di Vizio, J. Kim, M. H. Hager, M. Morello, W. Yang, C. J. Lafargue, L. D. True, M. A. Rubin, R. M. Adam, R. Beroukhim, et al. Oncosome Formation in Prostate Cancer: Association with a Region of Frequent Chromosomal Deletion in Metastatic Disease Cancer Res., July 1, 2009; 69(13): 5601 - 5609. [Abstract] [Full Text] [PDF]

				C. Sundberg, T. Friman, L. E. Hecht, C. Kuhl, and K. R. Solomon Two Different PDGF {beta}-Receptor Cohorts in Human Pericytes Mediate Distinct Biological Endpoints Am. J. Pathol., July 1, 2009; 175(1): 171 - 189. [Abstract] [Full Text] [PDF]

				I.-H. Lee, C. R. Campbell, S.-H. Song, M. L. Day, S. Kumar, D. I. Cook, and A. Dinudom The Activity of the Epithelial Sodium Channels Is Regulated by Caveolin-1 via a Nedd4-2-dependent Mechanism J. Biol. Chem., May 8, 2009; 284(19): 12663 - 12669. [Abstract] [Full Text] [PDF]

				N. K. Mukhopadhyay, J. Kim, B. Cinar, A. Ramachandran, M. H. Hager, D. Di Vizio, R. M. Adam, M. A. Rubin, P. Raychaudhuri, A. De Benedetti, et al. Heterogeneous Nuclear Ribonucleoprotein K Is a Novel Regulator of Androgen Receptor Translation Cancer Res., March 15, 2009; 69(6): 2210 - 2218. [Abstract] [Full Text] [PDF]

				X. Gao and J. Zhang Spatiotemporal Analysis of Differential Akt Regulation in Plasma Membrane Microdomains Mol. Biol. Cell, October 1, 2008; 19(10): 4366 - 4373. [Abstract] [Full Text] [PDF]

				S. Miersch, M. G. Espey, R. Chaube, A. Akarca, R. Tweten, S. Ananvoranich, and B. Mutus Plasma Membrane Cholesterol Content Affects Nitric Oxide Diffusion Dynamics and Signaling J. Biol. Chem., July 4, 2008; 283(27): 18513 - 18521. [Abstract] [Full Text] [PDF]

				S. R. Chinni, H. Yamamoto, Z. Dong, A. Sabbota, R. D. Bonfil, and M. L. Cher CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone Mol. Cancer Res., March 1, 2008; 6(3): 446 - 457. [Abstract] [Full Text] [PDF]

				B. Cinar, N. K. Mukhopadhyay, G. Meng, and M. R. Freeman Phosphoinositide 3-Kinase-independent Non-genomic Signals Transit from the Androgen Receptor to Akt1 in Membrane Raft Microdomains J. Biol. Chem., October 5, 2007; 282(40): 29584 - 29593. [Abstract] [Full Text] [PDF]